You are about to leave jnjmedicaldevices.com. By clicking to continue, you will be taken to a web site governed by their own Legal and Privacy Policies.
MONOVISC® High Molecular Weight Hyaluronan
MONOVISC® High Molecular Weight Hyaluronan is an FDA approved treatment made from ultra-pure hyaluronan, a naturally occurring lubricant found in healthy knee joints. MONOVISC® is a non-avian sourced viscosupplement that provides early and durable pain relief in a single high concentration injection that is conveniently packaged in a 4 mL volume for ease of use by physicians and minimum injection discomfort for patients.1
As OA of the knee progresses, prescription medications such as NSAIDs, COX-2 Inhibitors and intraarticular corticosteroid injections may be appropriate next course of therapy choices. Due to contraindications, co-morbidities or adverse events, COX-2 Inhibitors and/or NSAIDs may or may not be an appropriate choice.
These treatments may have provided relief to date but may no longer seem effective due to the disease state progression. A next-step consideration in the Continuum of Care for Knee Osteoarthritis is Hyaluronic Acid (HA) Injections, such as MONOVISC®.
Features & Benefits
-
High HA (Hyaluronic Acid) Concentration
High concentration maximizes the potential for impacting osteoarthritic cell function and restoring native HA production. MONOVISC is delivered as a 4 mL injection with an HA concentration 88mg per injection.1
-
Supporting Documentation
Resources
MONOVISC® White Paper
My Visco™ Patient Brochure
MONOVISC® Patient Brochure
References
1. Mitek Sports Medicine. “Clinical Efficacy and Safety of MONOVISC® High Molecular Weight Hyaluronan” June 2014. DSUS/MTK/0714/-232
Indication Statement
Indications for Use
Monovisc™ is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics (e.g., acetaminophen).
MONOVISC® Hyaluronan may enhance the viscoelastic properties of synovial fluid to relieve pain and increase mobility
MONOVISC® is manufactured by and is a registered trademark of Anika Therapeutics, Inc.
All medical devices have associated risks. Please refer to the package insert and other labeling for a complete list of indications, contraindications, precautions and warnings. For further information on DePuy Synthes Products, please contact your local DePuy Synthes Representative.
094212-180628
© DePuy Synthes 2021. All Rights Reserved. This site is published by the DePuy Synthes Companies, which are solely responsible for its content. This site is governed solely by applicable U.S. laws and governmental regulations. This site is for visitors from the United States. The third party trademarks used herein are the trademarks of their respective owners.